Variant Enzymes

US10081802B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10081802-B2
Application numberUS-201414909007-A
CountryUS
Kind codeB2
Filing dateJul 24, 2014
Priority dateJul 29, 2013
Publication dateSep 25, 2018
Grant dateSep 25, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Disclosed are glycosyl hydrolase enzyme variants, particularly variants of certain oxidoreductases of glycosyl hydrolase family 61. Nucleic acids encoding the glycosyl hydrolyase variants, compositions including the glycosyl hydrolase variants, methods of producing the variants, and methods of using the variants are also described.

First claim

Opening claim text (preview).

What is claimed is: 1. A variant of a parent glycoside hydrolase family 61 (GH61) enzyme, wherein said variant has cellulase activity, has at least 80% sequence identity to SEQ ID NO:3, wherein said variant comprises an amino acid substitution selected from the group consisting of: V104A, K106C, A129N, and combinations thereof. 2. The variant of claim 1 , wherein said variant comprises from 1 to 10 amino acid substitutions. 3. The variant of claim 2 , wherein said variant is a combinatorial variant. 4. The variant of claim 1 , wherein said parent GH61 polypeptide is a fungal glycosyl hydrolase 61a (GH61A). 5. The variant of claim 4 , wherein said fungal GH61A is from Hypocrea jecorina, Hypocrea rufa, Hypocrea orientalis, Hypocrea atroviridis, Hypocrea virens, Emericella nidulans, Aspergillus terreus, Aspergillus oryzae, Aspergillus niger, Aspergillus kawachii, Aspergillus flavus, Aspergillus clavatus, Gaeumannomyces graminis, Trichoderma saturnisporum, Neurospora tetrasperma, Neurospora crassa, Neosartorya fumigate, Neosartorya fumigate, Neosartorya fischeri, Thielavia terrestris, Talaromyces sp., Sporotricum sp, and Thielavia heterothallica. 6. The variant of claim 1 , wherein said variant has at least 90% sequence identity to SEQ ID NO:3. 7. The variant of claim 1 , wherein said variant has at least 95% sequence identity to SEQ ID NO:3. 8. A host cell comprising a polynucleotide encoding the variant of claim 1 . 9. The host cell of claim 8 , wherein said host cell is a fungal cell or a bacterial cell. 10. The host cell of claim 9 , wherein said fungal cell is a filamentous fungal cell selected from the group consisting of: Trichoderma reesei, Trichoderma longibrachiatum, Trichoderma viride, Trichoderma Trichoderma harzianum, Penicillium, Humicola, Humicola insolens, Humicola grisea, Chrysosporium, Chrysosporium lucknowense, Myceliophthora thermophilia, Gliocladium, Aspergillus, Fusarium, Neurospora, Hypocrea, Emericella, Aspergillus niger, Aspergillus awamori, Aspergillus aculeatus , and Aspergillus nidulans. 11. The host cell of claim 8 , wherein said host cell expresses the variant of a parent GH61 polypeptide encoded by said polynucleotide. 12. A composition comprising a GH61 variant according to claim 1 . 13. The composition of claim 12 , wherein said composition is selected from the group consisting of: a detergent, an animal feed, a feed additive, and a cell culture supernatant. 14. The composition of claim 12 , wherein said composition is enriched for said GH61 variant. 15. A method for hydrolyzing a cellulosic substrate, comprising contacting said substrate with a variant GH61 polypeptide according to claim 1 . 16. The method of claim 15 wherein the cellulosic substrate is wheat straw, corn stover or bagasse. 17. The method of claim 16 wherein the cellulosic substrate is pretreated. 18. The variant of claim 1 , wherein said variant has at least 99% sequence identity to SEQ ID NO:3. 19. The method of claim 15 wherein the variant has at least 99% sequence identity to SEQ ID NO: 3.

Assignees

Inventors

Classifications

  • hydrolysing O- and S- glycosyl compounds (3.2.1) · CPC title

  • produced by the action of a carbohydrase {(EC 3.2.x)}, e.g. by alpha-amylase {, e.g. by cellulase, hemicellulase} · CPC title

  • Miscellaneous (1.14.99) · CPC title

  • C12N9/2437Primary

    Cellulases (3.2.1.4; 3.2.1.74; 3.2.1.91; 3.2.1.150) · CPC title

  • Monosaccharides (2-ketogulonic acid C12P7/60) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10081802B2 cover?
Disclosed are glycosyl hydrolase enzyme variants, particularly variants of certain oxidoreductases of glycosyl hydrolase family 61. Nucleic acids encoding the glycosyl hydrolyase variants, compositions including the glycosyl hydrolase variants, methods of producing the variants, and methods of using the variants are also described.
Who is the assignee on this patent?
Danisco Us Inc
What technology area does this patent fall under?
Primary CPC classification C12N9/2437. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Sep 25 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).